Moderna | MRNA - Interest Income



Moderna reported $81M in Interest Income for its fiscal quarter ending in June of 2025.


Interest Income Change Date
Acadia Pharmaceuticals USD 7.24M 658K Jun/2025
Agios Pharmaceuticals USD 14.51M 1.57M Jun/2025
Alnylam Pharmaceuticals USD 27.49M 1.19M Jun/2025
Arrowhead Research USD 9.62M 2.01M Mar/2025
Biogen USD 32.3M 8.4M Jun/2025
BioMarin Pharmaceutical USD 18.83M 186K Jun/2025
Celltrion KRW 7.53B 1.21B Mar/2025
Dianthus Therapeutics USD 3.4M 587K Jun/2025
Gilead Sciences 73M 21M Jun/2025
GlaxoSmithKline 50M 4M Jun/2025
Incyte 25.14M 2.21M Jun/2025
Ionis Pharmaceuticals -0.66 0.29 Dec/2024
Kangmei Pharma 4.31M 8.34M Sep/2024
Knight Therapeutics CAD 2.46M 498K Sep/2024
Laboratorios Farma 139K 42K Jun/2025
Moderna USD 81M 9M Jun/2025
Pharma Mar 4.8M 6.4M Dec/2024
Qiagen NV USD 13.86M 1.53M Jun/2025
Regeneron Pharmaceuticals 174.8M 1.3M Jun/2025
Sarepta Therapeutics USD 7.14M 3.05M Jun/2025
Sartorius 54.9M 77.1M Mar/2025
Tilray USD 12.83M 20.19M May/2024
Ultragenyx Pharmaceutical USD 5.79M 1.04M Jun/2025
United Therapeutics USD 51.3M 200K Jun/2025
Vertex Pharmaceuticals USD 122.4M 1.5M Jun/2025
Zhangzhou Pientzehuang Pharmaceutical 2.63M 3.55M Mar/2025